与利妥昔单抗超适应症治疗多发性硬化症相关的单纯疱疹病毒性脑炎 - Suppr

HSV encephalitis associated with off-label rituximab treatment of multiple sclerosis.

作者信息

Montini Federico, Colombo Bruno, Giordano Antonino, Lopez Ingazio Diego, Moiola Lucia, Martinelli Vittorio, Filippi Massimo

机构信息

Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

出版信息

Neurol Sci. 2022 Mar;43(3):2095-2097. doi: 10.1007/s10072-021-05803-0. Epub 2022 Jan 9.

DOI:10.1007/s10072-021-05803-0

PMID:35000014

Abstract

摘要

相似文献

HSV encephalitis associated with off-label rituximab treatment of multiple sclerosis.

Neurol Sci. 2022 Mar;43(3):2095-2097. doi: 10.1007/s10072-021-05803-0. Epub 2022 Jan 9.

HSV-2-encephalitis in a patient with multiple sclerosis treated with ocrelizumab.

J Neurol. 2019 Sep;266(9):2322-2323. doi: 10.1007/s00415-019-09391-0. Epub 2019 May 21.

Extratemporal herpes encephalitis during natalizumab treatment: A case report.

Mult Scler Relat Disord. 2016 Nov;10:134-136. doi: 10.1016/j.msard.2016.10.002. Epub 2016 Oct 5.

Rituximab for treating multiple sclerosis: Off-label but on target.

Neurology. 2016 Nov 15;87(20):2070-2071. doi: 10.1212/WNL.0000000000003345. Epub 2016 Oct 19.

Rituximab-induced serum sickness in multiple sclerosis patients.

Mult Scler Relat Disord. 2019 Nov;36:101402. doi: 10.1016/j.msard.2019.101402. Epub 2019 Sep 17.

Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in Sweden.

JAMA Netw Open. 2021 Dec 1;4(12):e2136697. doi: 10.1001/jamanetworkopen.2021.36697.

Rituximab in the treatment of multiple sclerosis in the Hospital District of Southwest Finland.

Mult Scler Relat Disord. 2020 May;40:101980. doi: 10.1016/j.msard.2020.101980. Epub 2020 Feb 4.

Virus reactivation after immunotherapy of anti-NMDAR encephalitis secondary to herpes simplex encephalitis: A case report.

Brain Dev. 2021 Nov;43(10):1057-1060. doi: 10.1016/j.braindev.2021.06.005. Epub 2021 Jul 6.

A presentation of ulcerative colitis after rituximab therapy in a patient with multiple sclerosis and literature review.

Mult Scler Relat Disord. 2018 May;22:22-26. doi: 10.1016/j.msard.2018.02.030. Epub 2018 Mar 1.

Severe neutropenia after rituximab-treatment of multiple sclerosis.

Mult Scler Relat Disord. 2018 Feb;20:3-5. doi: 10.1016/j.msard.2017.12.005. Epub 2017 Dec 12.

引用本文的文献

B cells going viral in the CNS: Dynamics, complexities, and functions of B cells responding to viral encephalitis.

Immunol Rev. 2022 Oct;311(1):75-89. doi: 10.1111/imr.13124. Epub 2022 Aug 19.

本文引用的文献

A comparative study of tolerability and effects on immunoglobulin levels and CD19 cell counts with ocrelizumab vs low dose of rituximab in multiple sclerosis.

Mult Scler J Exp Transl Clin. 2020 Oct 12;6(4):2055217320964505. doi: 10.1177/2055217320964505. eCollection 2020 Oct-Dec.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

HSV encephalitis associated with off-label rituximab treatment of multiple sclerosis.

Neurol Sci. 2022 Mar;43(3):2095-2097. doi: 10.1007/s10072-021-05803-0. Epub 2022 Jan 9.

HSV-2-encephalitis in a patient with multiple sclerosis treated with ocrelizumab.

J Neurol. 2019 Sep;266(9):2322-2323. doi: 10.1007/s00415-019-09391-0. Epub 2019 May 21.

Extratemporal herpes encephalitis during natalizumab treatment: A case report.

Mult Scler Relat Disord. 2016 Nov;10:134-136. doi: 10.1016/j.msard.2016.10.002. Epub 2016 Oct 5.

Rituximab for treating multiple sclerosis: Off-label but on target.

Neurology. 2016 Nov 15;87(20):2070-2071. doi: 10.1212/WNL.0000000000003345. Epub 2016 Oct 19.

Rituximab-induced serum sickness in multiple sclerosis patients.

Mult Scler Relat Disord. 2019 Nov;36:101402. doi: 10.1016/j.msard.2019.101402. Epub 2019 Sep 17.

Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in Sweden.

JAMA Netw Open. 2021 Dec 1;4(12):e2136697. doi: 10.1001/jamanetworkopen.2021.36697.

Rituximab in the treatment of multiple sclerosis in the Hospital District of Southwest Finland.

Mult Scler Relat Disord. 2020 May;40:101980. doi: 10.1016/j.msard.2020.101980. Epub 2020 Feb 4.

Virus reactivation after immunotherapy of anti-NMDAR encephalitis secondary to herpes simplex encephalitis: A case report.

Brain Dev. 2021 Nov;43(10):1057-1060. doi: 10.1016/j.braindev.2021.06.005. Epub 2021 Jul 6.

A presentation of ulcerative colitis after rituximab therapy in a patient with multiple sclerosis and literature review.

Mult Scler Relat Disord. 2018 May;22:22-26. doi: 10.1016/j.msard.2018.02.030. Epub 2018 Mar 1.

Severe neutropenia after rituximab-treatment of multiple sclerosis.

Mult Scler Relat Disord. 2018 Feb;20:3-5. doi: 10.1016/j.msard.2017.12.005. Epub 2017 Dec 12.

引用本文的文献

B cells going viral in the CNS: Dynamics, complexities, and functions of B cells responding to viral encephalitis.

Immunol Rev. 2022 Oct;311(1):75-89. doi: 10.1111/imr.13124. Epub 2022 Aug 19.

本文引用的文献

A comparative study of tolerability and effects on immunoglobulin levels and CD19 cell counts with ocrelizumab vs low dose of rituximab in multiple sclerosis.

Mult Scler J Exp Transl Clin. 2020 Oct 12;6(4):2055217320964505. doi: 10.1177/2055217320964505. eCollection 2020 Oct-Dec.

HSV encephalitis associated with off-label rituximab treatment of multiple sclerosis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献